Detailed answers about STERLINGTON INJECTABLE PHARMACEUTICAL UK LTD, including incorporation, status, business activity, and accounts information.
When was STERLINGTON INJECTABLE PHARMACEUTICAL UK LTD founded?
STERLINGTON INJECTABLE PHARMACEUTICAL UK LTD was officially incorporated on 3 March 2026 and is registered under company number 17067636. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is STERLINGTON INJECTABLE PHARMACEUTICAL UK LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of STERLINGTON INJECTABLE PHARMACEUTICAL UK LTD?
STERLINGTON INJECTABLE PHARMACEUTICAL UK LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does STERLINGTON INJECTABLE PHARMACEUTICAL UK LTD do?
STERLINGTON INJECTABLE PHARMACEUTICAL UK LTD operates in the following sectors: 46460 - Wholesale of pharmaceutical goods, 46900 - Non-specialised wholesale trade. These SIC codes provide insight into the company's business activities and industry focus.
What is STERLINGTON INJECTABLE PHARMACEUTICAL UK LTD's registered address?
The registered office address of STERLINGTON INJECTABLE PHARMACEUTICAL UK LTD is 50 Princes Street, Ipswich, United Kingdom, IP1 1RJ. This is the official address filed with Companies House for legal and statutory correspondence.
Is STERLINGTON INJECTABLE PHARMACEUTICAL UK LTD financially stable?
Financial accounts for STERLINGTON INJECTABLE PHARMACEUTICAL UK LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.